WG Biotech ApS 13D and 13G filings for Y-mAbs Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB |
WG Biotech ApS | 4,700,533 10.700% |
395,402 (+9.18%) |
Filing |
| 2023-02-14 1:50 pm Purchase |
2019-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB |
WG Biotech ApS | 4,305,131 9.800% |
4,305,131 (New Position) |
Filing |